buff.ly
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
Outpatient treatment with metformin reduced long COVID incidence by about 41%, with
an absolute reduction of 4·1%, compared with placebo. Metformin has clinical benefits
when used as outpatient treatm...